Silver Mashate
Biographic Data
| ID | 9072668 |
|---|---|
| NAME | Silver Mashate |
| GIVEN NAMES | Silver |
| FAMILY NAME | Mashate |
| SIGNATURE | MASHATE S |
| AFFILIATIONS | African Society for Laboratory Medicine |
| ORCID | 0009-0002-6294-7358 |
| VERIFIED | Yes |
| TOTAL WORKS | 2 |
| TOTAL CITATIONS | 0 |
| AUTHOR COUNT | 2 |
| EDITOR COUNT | 0 |
| FIRST PUBLICATION YEAR | 2024 |
| LATEST PUBLICATION YEAR | 2026 |
| H-INDEX | 0 |
Reaching the 100 by 2027 target for universal access to rapid molecular diagnostic tests for tuberculosis in Africa
Although WHO recommended rapid molecular diagnostic tools for TB over a decade ago, only about one-third of diagnostic sites in high burden countries have access to them. We conducted a mixed-methods study to understand the barriers and facilitators to reaching universal access to WHO-recommended rapid molecular diagnostics (WRDs) in a selection of African countries. Data for 24 African countries were sourced from the WHO Global TB database to ev…
Diagnostics for detection and surveillance of priority epidemic-prone diseases in Africa
In 2023, Africa experienced 180 public health emergencies, of which 90% were infectious diseases and 75% were related to zoonotic diseases. Testing capacity for epidemic-prone diseases is essential to enable rapid and accurate identification of causative agents, and for action to prevent disease spread. Moreover, testing is pivotal in monitoring disease transmission, evaluating public health interventions and informing targeted resource allocatio…
No prominent works on this page.
Diagnostics for detection and surveillance of priority epidemic-prone diseases in Africa
In 2023, Africa experienced 180 public health emergencies, of which 90% were infectious diseases and 75% were related to zoonotic diseases. Testing capacity for epidemic-prone diseases is essential to enable rapid and accurate identification of causative agents, and for action to prevent disease spread. Moreover, testing is pivotal in monitoring disease transmission, evaluating public health interventions and informing targeted resource allocatio…
Reaching the 100 by 2027 target for universal access to rapid molecular diagnostic tests for tuberculosis in Africa
Although WHO recommended rapid molecular diagnostic tools for TB over a decade ago, only about one-third of diagnostic sites in high burden countries have access to them. We conducted a mixed-methods study to understand the barriers and facilitators to reaching universal access to WHO-recommended rapid molecular diagnostics (WRDs) in a selection of African countries. Data for 24 African countries were sourced from the WHO Global TB database to ev…
Business (1 work) · Capacity building (1 work) · Developing country (1 work) · Diagnosis and treatment of tuberculosis (1 work) · Diagnostic test (1 work) · Disease (1 work) · Disease surveillance (1 work) · Economic growth (1 work) · Economic shortage (1 work) · Environmental health (1 work)